80,000 Shares in Kenvue Inc. $KVUE Acquired by Mint Tower Capital Management B.V.

Mint Tower Capital Management B.V. bought a new stake in shares of Kenvue Inc. (NYSE:KVUE) during the 2nd quarter, Holdings Channel.com reports. The fund bought 80,000 shares of the company’s stock, valued at approximately $1,529,000.

Several other large investors have also recently made changes to their positions in KVUE. CoreCap Advisors LLC grew its stake in Kenvue by 64.9% in the second quarter. CoreCap Advisors LLC now owns 1,502 shares of the company’s stock valued at $29,000 after purchasing an additional 591 shares during the last quarter. Montag A & Associates Inc. lifted its position in shares of Kenvue by 6.3% during the first quarter. Montag A & Associates Inc. now owns 10,156 shares of the company’s stock valued at $175,000 after buying an additional 600 shares during the last quarter. Cornerstone Wealth Group LLC lifted its position in shares of Kenvue by 5.9% during the first quarter. Cornerstone Wealth Group LLC now owns 10,810 shares of the company’s stock valued at $187,000 after buying an additional 606 shares during the last quarter. Mill Creek Capital Advisors LLC boosted its holdings in shares of Kenvue by 0.6% in the 4th quarter. Mill Creek Capital Advisors LLC now owns 124,213 shares of the company’s stock valued at $2,143,000 after buying an additional 701 shares in the last quarter. Finally, B & T Capital Management DBA Alpha Capital Management boosted its holdings in shares of Kenvue by 0.3% in the 4th quarter. B & T Capital Management DBA Alpha Capital Management now owns 234,664 shares of the company’s stock valued at $4,048,000 after buying an additional 712 shares in the last quarter. 97.64% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the stock. Weiss Ratings upgraded shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, June 15th. Wall Street Zen downgraded shares of Kenvue from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. UBS Group cut their price target on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a report on Tuesday, August 11th. Barclays upped their price target on Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 21st. Finally, Zacks Research lowered Kenvue from a “strong-buy” rating to a “hold” rating in a report on Tuesday, July 7th. Three analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company. Based on data from MarketBeat, Kenvue presently has a consensus rating of “Hold” and an average price target of $19.27.

Kenvue Price Performance

Shares of KVUE stock opened at $19.15 on Friday. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $20.82. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.71 and a current ratio of 1.01. The firm has a market capitalization of $36.78 billion, a price-to-earnings ratio of 22.01, a PEG ratio of 1.37 and a beta of 0.47. The stock’s 50-day simple moving average is $19.16 and its 200-day simple moving average is $18.25.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.31 EPS for the quarter, missing the consensus estimate of $0.32 by ($0.01). The company had revenue of $3.96 billion during the quarter, compared to analysts’ expectations of $3.97 billion. Kenvue had a net margin of 10.76% and a return on equity of 21.22%. The business’s revenue for the quarter was up 3.0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.29 earnings per share. As a group, equities analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, August 26th. Shareholders of record on Wednesday, August 12th were issued a $0.21 dividend. This is an increase from Kenvue’s previous quarterly dividend of $0.21. This represents a $0.84 dividend on an annualized basis and a dividend yield of 4.4%. The ex-dividend date of this dividend was Wednesday, August 12th. Kenvue’s dividend payout ratio is 96.55%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over?the?counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.